Please provide your email address to receive an email when new articles are posted on . Medtronic announced that it has received FDA approval for a mobile app-based remote monitoring system for ...
The world’s very first fully implanted pacemaker, in 1958, lasted three hours before the batteries failed. It was replaced by one that lasted two days. Ultimately, Arne Larsson – surgical guinea pig – ...
Royal Philips Electronics has announced a new service that provides Web-based remote monitoring follow-up services for patients with pacemakers. The new service, which was made available to cardiology ...
Now it's official: Smart devices can do everything. Medtronic ($MDT) has launched the first app-based remote monitoring for implantable pacemakers. Remote monitoring ...
Data presented during a Late Breaking Clinical Trial at Heart Rhythm 2014 is the industry’s largest study of remote management of pacemaker patients ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical ...
The COMPAS study enrolled a total of 538 patients at 43 centers in France from February 2006 to January 2008. Patients, who presented with classic indications for a pacemaker, were implanted with a ...
A pacemaker from Medtronic, newly approved by the Food and Drug Administration, allows patients to securely transmit data from the pacemaker to their physicians via a smartphone or tablet using ...
Background: To determine the sensitivity and specificity, rate of compliance, and predictors of failure of telephone transmission of pacemaker function in a pediatric population. Methods: A total of 2 ...
Clinicians have been able to remotely monitor pacemakers for years thanks to a combination of near-field and remote wireless technologies, but until now, patients haven’t been able to access the data ...
is The Verge’s executive editor. He has covered tech, policy, and online creators for over a decade. The NSA is interested in collecting information from pacemakers and other biomedical devices for ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced that data presented during a Late Breaking Clinical Trial Session during Heart Rhythm ...